HC
ARRY

Henshaw Capital’s Array Biopharma Inc ARRY Stock Holding History

Henshaw Capital’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,846
Closed -$225K – 306
2019
Q2 		$225K Buy
+4,846
New +$136K 0.02% 253

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Henshaw Capital's ARRY Position: Q3 2019 in Review

Henshaw Capital sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 4,846 shares — an estimated $225K sold.

Henshaw Capital first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $225K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Henshaw Capital reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Henshaw Capital sold 4,846 Array Biopharma Inc shares in Q3 2019, an estimated $225K.
  • Henshaw Capital first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Henshaw Capital's Array Biopharma Inc position peaked at $225K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Henshaw Capital's 13F filing for Q3 2019, filed 28 May 2026.